Status | Study |
Terminated |
Study Name: Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Acute Basophilic Date: 2010-12-14 Interventions: Drug: Azacitidine Given SC |
Completed |
Study Name: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2010-08-05 Interventions: Drug: busulfan Given orally |
Active, not recruiting |
Study Name: Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Date: 2010-07-22 Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation |
Completed |
Study Name: Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Date: 2010-03-24 Interventions: Procedure: double-unit umbilical cord blood transplantation |
Completed |
Study Name: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia Condition: Adult Acute Monoblastic Leukemia (M5a) Adult Date: 2008-04-24 Interventions: Drug: idarubicin Given IV |
Active, not recruiting |
Study Name: Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Date: 2008-04-12 Interventions: Drug: Azacitidine Given IV or |
Active, not recruiting |
Study Name: Veliparib and Topotecan With or Without Carboplatin in Treating Patients With Relapsed or Refractory Acute Leukemia, High-Risk Myelodysplasia, or Aggressive Myeloproliferative Disorders Condition: Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Date: 2007-12-20 Interventions: Drug: Carboplatin Given IV |
Completed |
Study Name: Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor Condition: Leukemia, Monocytic, Acute Date: 2007-09-17 Interventions: Drug: Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantation |
Completed |
Study Name: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2006-09-29 Interventions: Drug: Bortezomib Given IV |
Completed |
Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukemia Date: 2005-09-20 Interventions: Drug: Sorafenib Tosylate Given orally Other Names: |